Pharma stock jumps 5% after receiving approval for Erythropoietin studies

Shares of a micro-cap pharmaceutical stock rose 5 percent following the approval from the Review Committee on Genetic Manipulation (RCGM) to initiate pre-clinical toxicity studies for its recombinant Erythropoietin product.  Share Price Movement  During Thursday’s trading session, Kwality Pharmaceuticals Ltd’s share price reached an intra-day high of Rs.909.95 per share, a 5 percent increase from … Continue reading Pharma stock jumps 5% after receiving approval for Erythropoietin studies